Snap Chart
What sets AI leaders apart in life sciences? They don’t just focus on what they build. They think just as much about how they scale it.
Scaling AI in life sciences takes more than technical prowess. Most companies recognize the importance of strong data foundations. But the innovators pull ahead by treating behavioral capabilities, like vision setting and building intuitive user experiences, as equally important to their AI programs.
In pharma and medtech, AI efforts rarely stall because of model performance alone. Rather, they stall when companies underestimate what’s required to scale or lose sight of the human element. Scaling leaders are setting a clear AI mandate, continuously improving development operations, and embedding AI into day-to-day work. And they deeply consider their human talent and the trust required for adoption.
Life Sciences’ AI Momentum Requires a Workforce Redesign
AI scalers aren't waiting for new talent—they're building it.
About Mayfield Fund
Mayfield Fund is a leading venture capital firm that backs early-stage entrepreneurs building impactful technology companies.
About our research partners
IncQuery is a leading programming provider of quantitative surveys for primary research. Its collaborative co-authoring platform, combined with support from experienced survey directors, empowers professionals to quickly launch high-quality surveys. Visit incquery.com for more information.
GLG connects clients to professionals with the firsthand experience they need, from the C-suite to the tractor seat, so they can make decisions with confidence.
First published in Ιανουάριος 2026